- Report
- April 2025
- 162 Pages
Global
From €4675EUR$4,950USD£3,976GBP
- Report
- February 2024
- 110 Pages
Global
From €4486EUR$4,750USD£3,815GBP
- Report
- March 2024
- 122 Pages
Africa, Middle East
From €3258EUR$3,450USD£2,771GBP
- Report
- March 2024
- 162 Pages
Europe
From €3258EUR$3,450USD£2,771GBP
- Report
- November 2023
- 280 Pages
Global
From €4203EUR$4,450USD£3,575GBP
- Report
- May 2023
- 87 Pages
Global
From €3500EUR$3,970USD£3,081GBP
- Report
- July 2022
- 78 Pages
Global
From €1889EUR$2,000USD£1,607GBP
- Book
- July 2022
- 560 Pages
United States
- Book
- September 2021
- 300 Pages
- Book
- October 2012
- 1570 Pages

The Parasitic Disease market is a subset of the Infectious Disease Testing market. It is composed of tests that detect the presence of parasites in the body, such as protozoa, helminths, and arthropods. These tests are used to diagnose and monitor the progression of parasitic infections, which can cause a variety of symptoms, including fever, abdominal pain, and diarrhea. Parasitic diseases are a major public health concern, particularly in developing countries, where they can lead to malnutrition, anemia, and even death.
The Parasitic Disease market is composed of a variety of diagnostic tests, including microscopy, antigen-detection tests, and molecular tests. These tests are used to detect the presence of parasites in the body, as well as to identify the species of the parasite.
Companies in the Parasitic Disease market include Alere, Bio-Rad Laboratories, Cepheid, DiaSorin, Hologic, Luminex, Qiagen, Roche, and Siemens Healthineers. Show Less Read more